Skip to main content
Erschienen in: Calcified Tissue International 2/2014

01.08.2014 | Original Research

Prevalence and Risk Factors of Low Bone Mineral Density in Juvenile Onset Ankylosing Spondylitis

verfasst von: Jun Bao, Yi Chen, Yi-Xiao Bao

Erschienen in: Calcified Tissue International | Ausgabe 2/2014

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study is to assess the prevalence and risk in patients with juvenile onset ankylosing spondylitis (JoAS) complicated with low bone mineral density (BMD). A total of 112 children and adolescents with JoAS were enrolled in the study. Bone mass was measured from the lumbar spine and the left proximal femur using dual-energy X-ray absorptiometry. According to the 2007 International Society of Clinical Densitometry definitions, a Z score of less than −2 was termed as “low BMD.” Stepwise regression analysis was used to investigate associations between low BMD and disease-related factors including gender, age, weight, height, body mass index, disease duration, HLA-B27 antigen, grades of sacroiliitis, Bath AS Disease Activity Index (BASDAI), Bath AS Functional Index (BASFI), patient global assessment (PGA), spine pain, erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Low BMD was found in 18 (16.1 %) cases in at least one of the two measured regions. Lumbar spine BMD had negative correlations with BASDAI, BASFI, spine pain, ESR, and CRP (P < 0.05). Hip BMD significantly negatively correlated with BASDAI and PGA (P < 0.05). In conclusion, patients with JoAS are likely to develop low BMD, which may be related to high disease activity.
Literatur
1.
Zurück zum Zitat Karberg K, Zochling J, Sieper J et al (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32(7):1290–1298PubMed Karberg K, Zochling J, Sieper J et al (2005) Bone loss is detected more frequently in patients with ankylosing spondylitis with syndesmophytes. J Rheumatol 32(7):1290–1298PubMed
2.
3.
Zurück zum Zitat Chen HA, Chen CH, Liao HT et al (2012) Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J Rheumatol 39(5):1013–1018PubMedCrossRef Chen HA, Chen CH, Liao HT et al (2012) Clinical, functional, and radiographic differences among juvenile-onset, adult-onset, and late-onset ankylosing spondylitis. J Rheumatol 39(5):1013–1018PubMedCrossRef
4.
Zurück zum Zitat van der Weijden MA, van Denderen JC, Lems WF et al (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30:497–503PubMedCentralPubMedCrossRef van der Weijden MA, van Denderen JC, Lems WF et al (2011) Low bone mineral density is related to male gender and decreased functional capacity in early spondylarthropathies. Clin Rheumatol 30:497–503PubMedCentralPubMedCrossRef
5.
Zurück zum Zitat Stagi S, Masi L, Capannini S et al (2010) Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. J Rheumatol 37:1935–1943PubMedCrossRef Stagi S, Masi L, Capannini S et al (2010) Cross-sectional and longitudinal evaluation of bone mass in children and young adults with juvenile idiopathic arthritis: the role of bone mass determinants in a large cohort of patients. J Rheumatol 37:1935–1943PubMedCrossRef
6.
Zurück zum Zitat van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 27:361–368PubMedCrossRef
7.
Zurück zum Zitat Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783PubMedCrossRef Rudwaleit M, van der Heijde D, Landewé R et al (2009) The development of Assessment of SpondyloArthritis International Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis 68:777–783PubMedCrossRef
8.
Zurück zum Zitat Tse SML, Laxer RM (2012) New advances in juvenile spondyloarthritis. Nat Rev Rheumatol 8(5):269–279PubMedCrossRef Tse SML, Laxer RM (2012) New advances in juvenile spondyloarthritis. Nat Rev Rheumatol 8(5):269–279PubMedCrossRef
9.
Zurück zum Zitat Reveille JD (2012) Genetic of spondyloarthritis-beyond the MHC. Nat Rev Rheumatol 8:296–304PubMedCrossRef Reveille JD (2012) Genetic of spondyloarthritis-beyond the MHC. Nat Rev Rheumatol 8:296–304PubMedCrossRef
10.
Zurück zum Zitat Rauch F, Plotkin H, DiMeglio L et al (2008) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 11:22–28PubMedCrossRef Rauch F, Plotkin H, DiMeglio L et al (2008) Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2007 Pediatric Official Positions. J Clin Densitom 11:22–28PubMedCrossRef
11.
Zurück zum Zitat Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed Garrett S, Jenkinson T, Kennedy LG et al (1994) A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 21:2286–2291PubMed
12.
Zurück zum Zitat Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed Calin A, Garrett S, Whitelock H et al (1994) A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath Ankylosing Spondylitis Functional Index. J Rheumatol 21:2281–2285PubMed
13.
Zurück zum Zitat Sambrook PN, Geusens P (2012) The epidemiology of osteoporosis and fractures in ankylosing spondylitis. Ther Adv Musculoskelet Dis 4(4):287–292PubMedCentralPubMedCrossRef Sambrook PN, Geusens P (2012) The epidemiology of osteoporosis and fractures in ankylosing spondylitis. Ther Adv Musculoskelet Dis 4(4):287–292PubMedCentralPubMedCrossRef
14.
Zurück zum Zitat Feldtkeller E, Vosse D, Geusens P et al (2006) Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int 26:234–239PubMedCrossRef Feldtkeller E, Vosse D, Geusens P et al (2006) Prevalence and annual incidence of vertebral fractures in patients with ankylosing spondylitis. Rheumatol Int 26:234–239PubMedCrossRef
15.
Zurück zum Zitat Klingberg E, Lorentzon M, Mellström D et al (2012) Osteoporosis in ankylosing spondylitis—prevalence, risk factors and methods of assessment. Arthritis Res Ther 14:R108–R119PubMedCentralPubMedCrossRef Klingberg E, Lorentzon M, Mellström D et al (2012) Osteoporosis in ankylosing spondylitis—prevalence, risk factors and methods of assessment. Arthritis Res Ther 14:R108–R119PubMedCentralPubMedCrossRef
16.
Zurück zum Zitat Huang CH, Wei JC, Hung PS et al (2011) Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. Rheumatology (Oxf) 50:359–365CrossRef Huang CH, Wei JC, Hung PS et al (2011) Osteoprotegerin genetic polymorphisms and age of symptom onset in ankylosing spondylitis. Rheumatology (Oxf) 50:359–365CrossRef
17.
Zurück zum Zitat Taylan A, Sari I, Akinci B et al (2012) Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. BMC Musculoskelet Disord 13:191–197PubMedCentralPubMedCrossRef Taylan A, Sari I, Akinci B et al (2012) Biomarkers and cytokines of bone turnover: extensive evaluation in a cohort of patients with ankylosing spondylitis. BMC Musculoskelet Disord 13:191–197PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Grazio S, Kusić Z, Cvijetić S et al (2012) Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 32:2801–2808PubMedCrossRef Grazio S, Kusić Z, Cvijetić S et al (2012) Relationship of bone mineral density with disease activity and functional ability in patients with ankylosing spondylitis: a cross-sectional study. Rheumatol Int 32:2801–2808PubMedCrossRef
19.
Zurück zum Zitat Aydin T, Karacan I, Demir SE et al (2005) Bone loss in males with ankylosing spondylitis: its relation to sex hormone levels. Clin Endocrinol (Oxf) 63:467–469CrossRef Aydin T, Karacan I, Demir SE et al (2005) Bone loss in males with ankylosing spondylitis: its relation to sex hormone levels. Clin Endocrinol (Oxf) 63:467–469CrossRef
20.
Zurück zum Zitat Arends S, Spoorenberg A, Bruyn GA et al (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 22:1431–1439PubMedCentralPubMedCrossRef Arends S, Spoorenberg A, Bruyn GA et al (2011) The relation between bone mineral density, bone turnover markers, and vitamin D status in ankylosing spondylitis patients with active disease: a cross-sectional analysis. Osteoporos Int 22:1431–1439PubMedCentralPubMedCrossRef
Metadaten
Titel
Prevalence and Risk Factors of Low Bone Mineral Density in Juvenile Onset Ankylosing Spondylitis
verfasst von
Jun Bao
Yi Chen
Yi-Xiao Bao
Publikationsdatum
01.08.2014
Verlag
Springer US
Erschienen in
Calcified Tissue International / Ausgabe 2/2014
Print ISSN: 0171-967X
Elektronische ISSN: 1432-0827
DOI
https://doi.org/10.1007/s00223-014-9867-2

Weitere Artikel der Ausgabe 2/2014

Calcified Tissue International 2/2014 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.